"we had (borrelia miyamotoi) as the new disease for the physicians to be aware of", told rusk..
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe....
“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.”